104 related articles for article (PubMed ID: 26116771)
1. Inhibition of invasion by glycogen synthase kinase-3 beta inhibitors through dysregulation of actin re-organisation via down-regulation of WAVE2.
Yoshino Y; Suzuki M; Takahashi H; Ishioka C
Biochem Biophys Res Commun; 2015 Aug; 464(1):275-80. PubMed ID: 26116771
[TBL] [Abstract][Full Text] [Related]
2. Potential Role of Glycogen Synthase Kinase-3β in Regulation of Myocardin Activity in Human Vascular Smooth Muscle Cells.
Zhou YX; Shi Z; Singh P; Yin H; Yu YN; Li L; Walsh MP; Gui Y; Zheng XL
J Cell Physiol; 2016 Feb; 231(2):393-402. PubMed ID: 26129946
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of glycogen synthase kinase-3 beta induces apoptosis and mitotic catastrophe by disrupting centrosome regulation in cancer cells.
Yoshino Y; Ishioka C
Sci Rep; 2015 Aug; 5():13249. PubMed ID: 26292722
[TBL] [Abstract][Full Text] [Related]
4. Signal transducers and activators of transcription 3-induced metastatic potential in gastric cancer cells is enhanced by glycogen synthase kinase-3β.
Yoon J; Ko YS; Cho SJ; Park J; Choi YS; Choi Y; Pyo JS; Ye SK; Youn HD; Lee JS; Chang MS; Kim MA; Lee BL
APMIS; 2015 May; 123(5):373-82. PubMed ID: 25846563
[TBL] [Abstract][Full Text] [Related]
5. Glycogen synthase kinase-3beta participates in nuclear factor kappaB-mediated gene transcription and cell survival in pancreatic cancer cells.
Ougolkov AV; Fernandez-Zapico ME; Savoy DN; Urrutia RA; Billadeau DD
Cancer Res; 2005 Mar; 65(6):2076-81. PubMed ID: 15781615
[TBL] [Abstract][Full Text] [Related]
6. Glycogen synthase kinase 3β dictates podocyte motility and focal adhesion turnover by modulating paxillin activity: implications for the protective effect of low-dose lithium in podocytopathy.
Xu W; Ge Y; Liu Z; Gong R
Am J Pathol; 2014 Oct; 184(10):2742-56. PubMed ID: 25239564
[TBL] [Abstract][Full Text] [Related]
7. Aberrant nuclear accumulation of glycogen synthase kinase-3beta in human pancreatic cancer: association with kinase activity and tumor dedifferentiation.
Ougolkov AV; Fernandez-Zapico ME; Bilim VN; Smyrk TC; Chari ST; Billadeau DD
Clin Cancer Res; 2006 Sep; 12(17):5074-81. PubMed ID: 16951223
[TBL] [Abstract][Full Text] [Related]
8. Glycogen synthase kinase-3β indirectly facilitates interferon-γ-induced nuclear factor-κB activation and nitric oxide biosynthesis.
Kai JI; Huang WC; Tsai CC; Chang WT; Chen CL; Lin CF
J Cell Biochem; 2010 Dec; 111(6):1522-30. PubMed ID: 20872791
[TBL] [Abstract][Full Text] [Related]
9. Glycogen synthase kinase-3β inhibition depletes the population of prostate cancer stem/progenitor-like cells and attenuates metastatic growth.
Kroon J; in 't Veld LS; Buijs JT; Cheung H; van der Horst G; van der Pluijm G
Oncotarget; 2014 Oct; 5(19):8986-94. PubMed ID: 25344861
[TBL] [Abstract][Full Text] [Related]
10. Rac-WAVE2 signaling is involved in the invasive and metastatic phenotypes of murine melanoma cells.
Kurisu S; Suetsugu S; Yamazaki D; Yamaguchi H; Takenawa T
Oncogene; 2005 Feb; 24(8):1309-19. PubMed ID: 15608687
[TBL] [Abstract][Full Text] [Related]
11. Polarized regulation of glycogen synthase kinase-3β is important for glioma cell invasion.
Zou Q; Hou Y; Shen F; Wang Y
PLoS One; 2013; 8(12):e81814. PubMed ID: 24312592
[TBL] [Abstract][Full Text] [Related]
12. Regulation of glycogen synthase kinase-3 beta (GSK-3β) by the Akt pathway in gliomas.
Atkins RJ; Dimou J; Paradiso L; Morokoff AP; Kaye AH; Drummond KJ; Hovens CM
J Clin Neurosci; 2012 Nov; 19(11):1558-63. PubMed ID: 22999562
[TBL] [Abstract][Full Text] [Related]
13. Glycogen synthase kinase 3β inhibition prevents monocyte migration across brain endothelial cells via Rac1-GTPase suppression and down-regulation of active integrin conformation.
Rom S; Fan S; Reichenbach N; Dykstra H; Ramirez SH; Persidsky Y
Am J Pathol; 2012 Oct; 181(4):1414-25. PubMed ID: 22863953
[TBL] [Abstract][Full Text] [Related]
14. Expression of junctional adhesion molecule-A prevents spontaneous and random motility.
Bazzoni G; Tonetti P; Manzi L; Cera MR; Balconi G; Dejana E
J Cell Sci; 2005 Feb; 118(Pt 3):623-32. PubMed ID: 15657074
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of amyloid-β through AMPK activation by inhibitors of GSK-3β in SH-SY5Y and SH-SY5Y-AβPP695 cells.
Cai Z; Li B; Li K; Zhao B
J Alzheimers Dis; 2012; 29(1):89-98. PubMed ID: 22214783
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of endothelial progenitor cell glycogen synthase kinase-3beta results in attenuated neointima formation and enhanced re-endothelialization after arterial injury.
Hibbert B; Ma X; Pourdjabbar A; Holm E; Rayner K; Chen YX; Sun J; Filion L; O'Brien ER
Cardiovasc Res; 2009 Jul; 83(1):16-23. PubMed ID: 19454488
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of GSK-3β reverses the pro-apoptotic effect of proadifen (SKF-525A) in HT-29 colon adenocarcinoma cells.
Jendželovský R; Koval J; Mikeš J; Papčová Z; Plšíková J; Fedoročko P
Toxicol In Vitro; 2012 Sep; 26(6):775-82. PubMed ID: 22683934
[TBL] [Abstract][Full Text] [Related]
18. Glycogen synthase kinase-3beta activity is required for androgen-stimulated gene expression in prostate cancer.
Liao X; Thrasher JB; Holzbeierlein J; Stanley S; Li B
Endocrinology; 2004 Jun; 145(6):2941-9. PubMed ID: 14988390
[TBL] [Abstract][Full Text] [Related]
19. Glycogen synthase kinase-3 beta inhibitor suppresses Porphyromonas gingivalis lipopolysaccharide-induced CD40 expression by inhibiting nuclear factor-kappa B activation in mouse osteoblasts.
Die L; Yan P; Jun Jiang Z; Min Hua T; Cai W; Xing L
Mol Immunol; 2012 Aug; 52(1):38-49. PubMed ID: 22580404
[TBL] [Abstract][Full Text] [Related]
20. Maintenance of constitutive IkappaB kinase activity by glycogen synthase kinase-3alpha/beta in pancreatic cancer.
Wilson W; Baldwin AS
Cancer Res; 2008 Oct; 68(19):8156-63. PubMed ID: 18829575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
